FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1782-1783 December 28, 1995 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kinloch-de Loës, S.

To the Editor: In an editorial on the studies of early treatment of human immunodeficiency virus (HIV) infection by Kinloch-de Loës et al.¹ and Volberding et al.,² Dr. Ho (Aug. 17 issue)³ cites a study showing that the plateau concentration of viral RNA after primary HIV type 1 (HIV-1) infection predicts the clinical outcome. He suggests that "treatment at the time of seroconversion may lower the initial viral plateau (`set point') and thereby improve the subsequent clinical course." Kinloch-de Loës et al. state that "the administration of antiviral therapy at the time of primary HIV infection is intended to decrease . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.